COMMUNIQUÉS West-GlobeNewswire
-
IQity Draws Strong Surgeon Interest at First Exhibition Debut, AAO 2026
22/10/2026 -
Nordic Naturals Experts Share the Four Questions Every Consumer Should Ask About Their Supplements
22/10/2026 -
Foundation for Sarcoidosis Research Welcomes Nine New Members to the FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA)
22/10/2026 -
A Race Against Blindness Celebrates Recent Fundraiser Winners During Blindness Awareness Month
22/10/2026 -
New Study Finds Pycnogenol® Improves Quality of Life and Symptoms Associated with Osteopenia and Osteoporosis in Post-Menopausal Women
22/10/2026 -
FEM By UPSA Appoints U.S. Advisors to Advance Science-Backed, Non-Hormonal Menopause Support
22/10/2026 -
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
22/10/2026 -
Beacon Biosignals Acquires Snap Diagnostics, Paving the Way for EEG-Enabled Home Sleep Testing in Every Care Setting
22/10/2026 -
Claritas and Qubiotech join forces to build an independent challenger in quantitative PET — from whole body to brain
22/10/2026 -
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
22/10/2026 -
Integrity Urgent Care Clinic Opens in McKinney, Texas
22/10/2026 -
Founded by MIT and Flagship Alum, AI Drug Discovery Company Reflector Bio Emerges from Stealth
22/10/2026 -
SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026
22/10/2026 -
Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine
22/10/2026 -
Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors
22/10/2026 -
Guerbet : Revenue at 30 September 2026.
22/10/2026 -
Guerbet : Chiffre d’affaires au 30 septembre 2026.
22/10/2026 -
One04 Therapeutics presents positive interim Phase 1 data for CPV-104 in C3 glomerulopathy in ASN Kidney Week late-breaker
22/10/2026 -
Regulated information: Disclosure of a transparency notification from Aberdeen Group plc
22/10/2026
Pages